Sep 09, 2019 / 08:15PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Good afternoon, everybody. We're going to get started with the next session. I am Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly, before we get started, I need to read a disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up a copy at the registration desk. So very pleased to have Moderna with me for the next presentation and Stéphane Bancel, the CEO. Stéphane, I don't know if you want to make any opening comments or we should just jump right into it.
Stéphane Bancel - Moderna, Inc. - CEO & Director
Go, go for it.
Questions and Answers:
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive DirectorAll right. So I think a couple of high-level platform questions are probably